Erectile Dysfunction Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
Erectile Dysfunction Treatment Market: Global Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012-2016 and Forecast 2017-2023
(EMAILWIRE.COM, November 30, 2017 ) Erectile dysfunction treatment market report gives comprehensive outlook on erectile dysfunction across the globe with special emphasis on key regions such as North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa (MEA). This report on erectile dysfunction market gives historical, current, and future market sizes (US$ Mn) of product, distribution channel and geographic regions. This report studies erectile dysfunction market dynamics elaborately to identify the current trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, the market report includes regulatory scenario, and competition analysis with vividly illustrated the competition dashboard to assess the market competition. Moreover, PBI analyzed erectile dysfunction market to better equip clients with possible investment opportunities across the regions (Regional Investment Hot-Spots) and market unmet needs (Product Opportunities). Key stakeholders of the erectile dysfunction market report include suppliers, manufacturers, marketers, policy makers engaged in manufacturing and supply of erectile dysfunction.
A sample of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-erectile-dysfunction-treatment-market/#ulp-4H8Z4LpNMLEuOnnx
Erectile Dysfunction Market:
The erectile dysfunction market estimated to be valued US$ XX Mn in 2016 and expanding at a growth rate of 4.2%, and projected to reach US$ XX Mn by 2023.
Is patent cliff of major brands leading to sluggish growth of erectile dysfunction market?
The erectile dysfunction treatment market is expected to grow at slow rate due to patent expiry of major brands. For instance, Viagras patent expired outside the U.S. in 2012, in U.S set to expire, but Pfizers collaboration with Teva and Mylan to introduce generics in U.S. in December 2017. Patent expiration of blockbuster molecules, availability of alternatives such as penus pumps, penile implants, ayurvedic medicines are expected to dampen the market growth.
Does erectile dysfunction treatment market unlock the potential of generic drugs?
Surge in R&D expenditure to develop alternatives to patented molecules, patent expiration of leading brands are expected to offer enormous opportunities for players.
Asia Pacific erectile dysfunction market expected to expand at robust CAGR over the forecast period.
U.S. erectile dysfunction market witnessed significant revenue share owing to increased number of patients suffer from erectile dysfunction (ED). The prevalence of ED associated with age, diabetes, cardiovascular disorders. As per statistics, about 18 million men over age of 20 suffer from ED. Increased awareness, availability of treatment are few factors enables drive the market. Asia Pacific erectile dysfunction market is expanding at healthy growth rate. Large patient pool, soaring old age male population expected to create strides in Asia Pacific ED treatment market. China & India expected to witness lucrative growth opportunities for generic manufacturers. Players are focused on develop alternatives to expensive patented drugs, increased awareness, surge in economy & disposable income expected to drive emerging countries erectile dysfunction market.
To view TOC of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-erectile-dysfunction-treatment-market/#ulp-c654SbFYO64MsOhu
Patent cliffs, availability of alternative therapies and devices, adverse effects like cardiovascular disorders, abnormalities in blood pressure; severe headache are road blocks for the erectile dysfunction market.
Competition Assessment
Key players profiles in the global erectile dysfunction market include:
Pfizer, Inc. (U.S)
Bayer AG (Germany)
Eli Lilly and Company (U.S)
(Brazil)
Apricus Biosciences Inc. (U.S)
Meda Pharmaceuticals, Inc. (U.S)
K. Chemicals Co. Ltd.(Korea)
Vivus, Inc. (U.S)
Dong-A ST (South Korea)
Market players are focusing on mergers and acquisitions to improve their market position in Erectile Dysfunction market. On 27 March, 2017, Vivus receive STENDRA (R) commercial rights from Sanofi, to Africa, Middle East, Turkey, and Russia.
Need more information about this report @https://www.precisionbusinessinsights.com/market-reports/global-erectile-dysfunction-treatment-market/#ulp-14mlyhjMGhVjZqa3
Key Findings of the Report:
Erectile dysfunction market is expanding at 4.2% CAGR over 2017 to 2023 to reach market value of US$ XX Mn by 2023
Based on type, predictive analytics market is expanding at highest CAGR over the forecast period.
Based on region type, North America is expected to account for major market share.
Hospitals are prime channel for surgical instruments systems distribution across the globe
Players focusing on expanding geographic presence to garner market opportunities in developing economies
Detailed Segmentation
By Product
Seldinafil [Viagra]
Tadalafil [Adcirca, Cialis]
Vardenafil [Staxyn, Levitra]
Avanafil [Stendra]
Others
By Distribution Channel
Hospitals
Clinics
Others
Get access to full summary @https://www.precisionbusinessinsights.com/market-reports/global-erectile-dysfunction-treatment-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @https://www.precisionbusinessinsights.com
A sample of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-erectile-dysfunction-treatment-market/#ulp-4H8Z4LpNMLEuOnnx
Erectile Dysfunction Market:
The erectile dysfunction market estimated to be valued US$ XX Mn in 2016 and expanding at a growth rate of 4.2%, and projected to reach US$ XX Mn by 2023.
Is patent cliff of major brands leading to sluggish growth of erectile dysfunction market?
The erectile dysfunction treatment market is expected to grow at slow rate due to patent expiry of major brands. For instance, Viagras patent expired outside the U.S. in 2012, in U.S set to expire, but Pfizers collaboration with Teva and Mylan to introduce generics in U.S. in December 2017. Patent expiration of blockbuster molecules, availability of alternatives such as penus pumps, penile implants, ayurvedic medicines are expected to dampen the market growth.
Does erectile dysfunction treatment market unlock the potential of generic drugs?
Surge in R&D expenditure to develop alternatives to patented molecules, patent expiration of leading brands are expected to offer enormous opportunities for players.
Asia Pacific erectile dysfunction market expected to expand at robust CAGR over the forecast period.
U.S. erectile dysfunction market witnessed significant revenue share owing to increased number of patients suffer from erectile dysfunction (ED). The prevalence of ED associated with age, diabetes, cardiovascular disorders. As per statistics, about 18 million men over age of 20 suffer from ED. Increased awareness, availability of treatment are few factors enables drive the market. Asia Pacific erectile dysfunction market is expanding at healthy growth rate. Large patient pool, soaring old age male population expected to create strides in Asia Pacific ED treatment market. China & India expected to witness lucrative growth opportunities for generic manufacturers. Players are focused on develop alternatives to expensive patented drugs, increased awareness, surge in economy & disposable income expected to drive emerging countries erectile dysfunction market.
To view TOC of this report is available upon request @https://www.precisionbusinessinsights.com/market-reports/global-erectile-dysfunction-treatment-market/#ulp-c654SbFYO64MsOhu
Patent cliffs, availability of alternative therapies and devices, adverse effects like cardiovascular disorders, abnormalities in blood pressure; severe headache are road blocks for the erectile dysfunction market.
Competition Assessment
Key players profiles in the global erectile dysfunction market include:
Pfizer, Inc. (U.S)
Bayer AG (Germany)
Eli Lilly and Company (U.S)
(Brazil)
Apricus Biosciences Inc. (U.S)
Meda Pharmaceuticals, Inc. (U.S)
K. Chemicals Co. Ltd.(Korea)
Vivus, Inc. (U.S)
Dong-A ST (South Korea)
Market players are focusing on mergers and acquisitions to improve their market position in Erectile Dysfunction market. On 27 March, 2017, Vivus receive STENDRA (R) commercial rights from Sanofi, to Africa, Middle East, Turkey, and Russia.
Need more information about this report @https://www.precisionbusinessinsights.com/market-reports/global-erectile-dysfunction-treatment-market/#ulp-14mlyhjMGhVjZqa3
Key Findings of the Report:
Erectile dysfunction market is expanding at 4.2% CAGR over 2017 to 2023 to reach market value of US$ XX Mn by 2023
Based on type, predictive analytics market is expanding at highest CAGR over the forecast period.
Based on region type, North America is expected to account for major market share.
Hospitals are prime channel for surgical instruments systems distribution across the globe
Players focusing on expanding geographic presence to garner market opportunities in developing economies
Detailed Segmentation
By Product
Seldinafil [Viagra]
Tadalafil [Adcirca, Cialis]
Vardenafil [Staxyn, Levitra]
Avanafil [Stendra]
Others
By Distribution Channel
Hospitals
Clinics
Others
Get access to full summary @https://www.precisionbusinessinsights.com/market-reports/global-erectile-dysfunction-treatment-market/
About Precision Business Insights
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact to Precision Business Insights,
Kemp House,
152 160 City Road,
London EC1V 2NX
Email: sales@precisionbusinessinsights.com
Toll Free (US): +1-866-598-1553
Website @https://www.precisionbusinessinsights.com
Contact Information:
Precision Business Insights
Sales
Tel: +1-866-598-1553
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results
Precision Business Insights
Sales
Tel: +1-866-598-1553
Email us
----
This press release is posted on EmailWire.com -- a global newswire that provides Press Release Distribution Services with Guaranteed Results